XML 70 R55.htm IDEA: XBRL DOCUMENT v3.19.1
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2019
Apr. 01, 2018
Sales by segment of business    
Sales to customers $ 20,021 $ 20,009
Percent Change (as a percent) 0.10%  
U.S.    
Sales by segment of business    
Sales to customers $ 10,129 9,951
Percent Change (as a percent) 1.80%  
International    
Sales by segment of business    
Sales to customers $ 9,892 10,058
Percent Change (as a percent) (1.70%)  
CONSUMER    
Sales by segment of business    
Sales to customers $ 3,318 3,398
Percent Change (as a percent) (2.40%)  
CONSUMER | U.S.    
Sales by segment of business    
Sales to customers $ 1,438 1,436
Percent Change (as a percent) 0.20%  
CONSUMER | International    
Sales by segment of business    
Sales to customers $ 1,880 1,962
Percent Change (as a percent) (4.20%)  
CONSUMER | Baby Care    
Sales by segment of business    
Sales to customers $ 394 457
Percent Change (as a percent) (14.00%)  
CONSUMER | Baby Care | U.S.    
Sales by segment of business    
Sales to customers $ 87 97
Percent Change (as a percent) (10.90%)  
CONSUMER | Baby Care | International    
Sales by segment of business    
Sales to customers $ 307 360
Percent Change (as a percent) (14.80%)  
CONSUMER | Beauty    
Sales by segment of business    
Sales to customers $ 1,090 1,084
Percent Change (as a percent) 0.60%  
CONSUMER | Beauty | U.S.    
Sales by segment of business    
Sales to customers $ 588 611
Percent Change (as a percent) (3.80%)  
CONSUMER | Beauty | International    
Sales by segment of business    
Sales to customers $ 502 473
Percent Change (as a percent) 6.20%  
CONSUMER | Oral Care    
Sales by segment of business    
Sales to customers $ 367 379
Percent Change (as a percent) (3.10%)  
CONSUMER | Oral Care | U.S.    
Sales by segment of business    
Sales to customers $ 151 157
Percent Change (as a percent) (3.50%)  
CONSUMER | Oral Care | International    
Sales by segment of business    
Sales to customers $ 216 222
Percent Change (as a percent) (2.80%)  
CONSUMER | OTC    
Sales by segment of business    
Sales to customers $ 1,087 1,072
Percent Change (as a percent) 1.30%  
CONSUMER | OTC | U.S.    
Sales by segment of business    
Sales to customers $ 507 465
Percent Change (as a percent) 9.10%  
CONSUMER | OTC | International    
Sales by segment of business    
Sales to customers $ 580 607
Percent Change (as a percent) (4.60%)  
CONSUMER | Women's Health    
Sales by segment of business    
Sales to customers $ 225 243
Percent Change (as a percent) (7.30%)  
CONSUMER | Women's Health | U.S.    
Sales by segment of business    
Sales to customers $ 3 3
Percent Change (as a percent) 4.20%  
CONSUMER | Women's Health | International    
Sales by segment of business    
Sales to customers $ 222 240
Percent Change (as a percent) (7.50%)  
CONSUMER | Wound Care/Other    
Sales by segment of business    
Sales to customers $ 155 163
Percent Change (as a percent) (4.80%)  
CONSUMER | Wound Care/Other | U.S.    
Sales by segment of business    
Sales to customers $ 102 103
Percent Change (as a percent) (0.90%)  
CONSUMER | Wound Care/Other | International    
Sales by segment of business    
Sales to customers $ 53 60
Percent Change (as a percent) (11.60%)  
PHARMACEUTICAL    
Sales by segment of business    
Sales to customers $ 10,244 9,844
Percent Change (as a percent) 4.10%  
PHARMACEUTICAL | U.S.    
Sales by segment of business    
Sales to customers $ 5,582 5,354
Percent Change (as a percent) 4.30%  
PHARMACEUTICAL | International    
Sales by segment of business    
Sales to customers $ 4,662 4,490
Percent Change (as a percent) 3.90%  
PHARMACEUTICAL | Immunology    
Sales by segment of business    
Sales to customers $ 3,251 3,042
Percent Change (as a percent) 6.90%  
PHARMACEUTICAL | Immunology | U.S.    
Sales by segment of business    
Sales to customers $ 2,163 2,000
Percent Change (as a percent) 8.10%  
PHARMACEUTICAL | Immunology | International    
Sales by segment of business    
Sales to customers $ 1,088 1,042
Percent Change (as a percent) 4.50%  
PHARMACEUTICAL | Immunology | REMICADE®    
Sales by segment of business    
Sales to customers $ 1,102 1,389
Percent Change (as a percent) (20.60%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S.    
Sales by segment of business    
Sales to customers $ 774 916
Percent Change (as a percent) (15.50%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports    
Sales by segment of business    
Sales to customers $ 76 142
Percent Change (as a percent) (46.40%)  
PHARMACEUTICAL | Immunology | REMICADE® | International    
Sales by segment of business    
Sales to customers $ 252 331
Percent Change (as a percent) (23.60%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®    
Sales by segment of business    
Sales to customers $ 524 518
Percent Change (as a percent) 1.00%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.    
Sales by segment of business    
Sales to customers $ 263 224
Percent Change (as a percent) 17.00%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International    
Sales by segment of business    
Sales to customers $ 261 294
Percent Change (as a percent) (11.10%)  
PHARMACEUTICAL | Immunology | STELARA®    
Sales by segment of business    
Sales to customers $ 1,405 1,061
Percent Change (as a percent) 32.40%  
PHARMACEUTICAL | Immunology | STELARA® | U.S.    
Sales by segment of business    
Sales to customers $ 882 652
Percent Change (as a percent) 35.20%  
PHARMACEUTICAL | Immunology | STELARA® | International    
Sales by segment of business    
Sales to customers $ 523 409
Percent Change (as a percent) 27.90%  
PHARMACEUTICAL | Immunology | TREMFYA®    
Sales by segment of business    
Sales to customers $ 217 72
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.    
Sales by segment of business    
Sales to customers 168 66
PHARMACEUTICAL | Immunology | TREMFYA® | International    
Sales by segment of business    
Sales to customers 49 6
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY    
Sales by segment of business    
Sales to customers $ 3 2
Percent Change (as a percent) 19.50%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International    
Sales by segment of business    
Sales to customers $ 3 2
Percent Change (as a percent) 19.50%  
PHARMACEUTICAL | Infectious Diseases    
Sales by segment of business    
Sales to customers $ 846 830
Percent Change (as a percent) 1.90%  
PHARMACEUTICAL | Infectious Diseases | U.S.    
Sales by segment of business    
Sales to customers $ 357 333
Percent Change (as a percent) 7.30%  
PHARMACEUTICAL | Infectious Diseases | International    
Sales by segment of business    
Sales to customers $ 489 497
Percent Change (as a percent) (1.70%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine    
Sales by segment of business    
Sales to customers $ 211 210
Percent Change (as a percent) 0.80%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.    
Sales by segment of business    
Sales to customers $ 12 14
Percent Change (as a percent) (18.80%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International    
Sales by segment of business    
Sales to customers $ 199 196
Percent Change (as a percent) 2.20%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®    
Sales by segment of business    
Sales to customers $ 523 478
Percent Change (as a percent) 9.50%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.    
Sales by segment of business    
Sales to customers $ 315 273
Percent Change (as a percent) 15.50%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International    
Sales by segment of business    
Sales to customers $ 208 205
Percent Change (as a percent) 1.50%  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES    
Sales by segment of business    
Sales to customers $ 112 142
Percent Change (as a percent) (21.70%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.    
Sales by segment of business    
Sales to customers $ 30 46
Percent Change (as a percent) (33.80%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International    
Sales by segment of business    
Sales to customers $ 82 96
Percent Change (as a percent) (16.00%)  
PHARMACEUTICAL | Neuroscience    
Sales by segment of business    
Sales to customers $ 1,629 1,559
Percent Change (as a percent) 4.50%  
PHARMACEUTICAL | Neuroscience | U.S.    
Sales by segment of business    
Sales to customers $ 723 624
Percent Change (as a percent) 16.00%  
PHARMACEUTICAL | Neuroscience | International    
Sales by segment of business    
Sales to customers $ 905 935
Percent Change (as a percent) (3.20%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate    
Sales by segment of business    
Sales to customers $ 214 173
Percent Change (as a percent) 23.40%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | U.S.    
Sales by segment of business    
Sales to customers $ 97 66
Percent Change (as a percent) 47.70%  
PHARMACEUTICAL | Neuroscience | CONCERTA® / Methylphenidate | International    
Sales by segment of business    
Sales to customers $ 116 107
Percent Change (as a percent) 8.50%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®    
Sales by segment of business    
Sales to customers $ 790 696
Percent Change (as a percent) 13.50%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.    
Sales by segment of business    
Sales to customers $ 483 400
Percent Change (as a percent) 20.70%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International    
Sales by segment of business    
Sales to customers $ 307 296
Percent Change (as a percent) 3.80%  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®    
Sales by segment of business    
Sales to customers $ 179 196
Percent Change (as a percent) (8.80%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.    
Sales by segment of business    
Sales to customers $ 77 82
Percent Change (as a percent) (6.80%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International    
Sales by segment of business    
Sales to customers $ 102 114
Percent Change (as a percent) (10.30%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE    
Sales by segment of business    
Sales to customers $ 446 494
Percent Change (as a percent) (9.60%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.    
Sales by segment of business    
Sales to customers $ 66 76
Percent Change (as a percent) (12.00%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International    
Sales by segment of business    
Sales to customers $ 379 418
Percent Change (as a percent) (9.20%)  
PHARMACEUTICAL | Oncology    
Sales by segment of business    
Sales to customers $ 2,518 2,311
Percent Change (as a percent) 9.00%  
PHARMACEUTICAL | Oncology | U.S.    
Sales by segment of business    
Sales to customers $ 962 933
Percent Change (as a percent) 3.10%  
PHARMACEUTICAL | Oncology | International    
Sales by segment of business    
Sales to customers $ 1,556 1,378
Percent Change (as a percent) 13.00%  
PHARMACEUTICAL | Oncology | DARZALEX®    
Sales by segment of business    
Sales to customers $ 629 432
Percent Change (as a percent) 45.50%  
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.    
Sales by segment of business    
Sales to customers $ 352 264
Percent Change (as a percent) 33.00%  
PHARMACEUTICAL | Oncology | DARZALEX® | International    
Sales by segment of business    
Sales to customers $ 277 168
Percent Change (as a percent) 65.10%  
PHARMACEUTICAL | Oncology | IMBRUVICA®    
Sales by segment of business    
Sales to customers $ 784 587
Percent Change (as a percent) 33.50%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.    
Sales by segment of business    
Sales to customers $ 349 227
Percent Change (as a percent) 53.70%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | International    
Sales by segment of business    
Sales to customers $ 435 360
Percent Change (as a percent) 20.80%  
PHARMACEUTICAL | Oncology | VELCADE®    
Sales by segment of business    
Sales to customers $ 263 313
Percent Change (as a percent) (16.00%)  
PHARMACEUTICAL | Oncology | VELCADE® | U.S.    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
PHARMACEUTICAL | Oncology | VELCADE® | International    
Sales by segment of business    
Sales to customers $ 263 313
Percent Change (as a percent) (16.00%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate    
Sales by segment of business    
Sales to customers $ 679 845
Percent Change (as a percent) (19.60%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.    
Sales by segment of business    
Sales to customers $ 185 407
Percent Change (as a percent) (54.50%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International    
Sales by segment of business    
Sales to customers $ 494 438
Percent Change (as a percent) 12.90%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY    
Sales by segment of business    
Sales to customers $ 163 134
Percent Change (as a percent) 21.70%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.    
Sales by segment of business    
Sales to customers $ 76 35
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International    
Sales by segment of business    
Sales to customers $ 87 99
Percent Change (as a percent) (12.20%)  
PHARMACEUTICAL | Pulmonary Hypertension    
Sales by segment of business    
Sales to customers $ 656 585
Percent Change (as a percent) 12.10%  
PHARMACEUTICAL | Pulmonary Hypertension | U.S.    
Sales by segment of business    
Sales to customers $ 430 361
Percent Change (as a percent) 19.20%  
PHARMACEUTICAL | Pulmonary Hypertension | International    
Sales by segment of business    
Sales to customers $ 226 224
Percent Change (as a percent) 0.70%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®    
Sales by segment of business    
Sales to customers $ 306 271
Percent Change (as a percent) 12.70%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.    
Sales by segment of business    
Sales to customers $ 172 149
Percent Change (as a percent) 15.90%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International    
Sales by segment of business    
Sales to customers $ 133 122
Percent Change (as a percent) 8.90%  
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER®    
Sales by segment of business    
Sales to customers $ 117 140
Percent Change (as a percent) (16.70%)  
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | U.S.    
Sales by segment of business    
Sales to customers $ 61 68
Percent Change (as a percent) (10.10%)  
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | International    
Sales by segment of business    
Sales to customers $ 56 72
Percent Change (as a percent) (22.90%)  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®    
Sales by segment of business    
Sales to customers $ 198 140
Percent Change (as a percent) 41.60%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.    
Sales by segment of business    
Sales to customers $ 176 124
Percent Change (as a percent) 41.40%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International    
Sales by segment of business    
Sales to customers $ 22 16
Percent Change (as a percent) 42.80%  
PHARMACEUTICAL | Pulmonary Hypertension | OTHER    
Sales by segment of business    
Sales to customers $ 35 34
Percent Change (as a percent) 4.00%  
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 21 20
Percent Change (as a percent) 3.60%  
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | International    
Sales by segment of business    
Sales to customers $ 15 14
Percent Change (as a percent) 4.60%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other    
Sales by segment of business    
Sales to customers $ 1,345 1,517
Percent Change (as a percent) (11.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.    
Sales by segment of business    
Sales to customers $ 947 1,103
Percent Change (as a percent) (14.10%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International    
Sales by segment of business    
Sales to customers $ 398 414
Percent Change (as a percent) (3.90%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®    
Sales by segment of business    
Sales to customers $ 542 578
Percent Change (as a percent) (6.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.    
Sales by segment of business    
Sales to customers $ 542 578
Percent Change (as a percent) (6.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International    
Sales by segment of business    
Sales to customers $ 0 0
Percent Change (as a percent) 0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®    
Sales by segment of business    
Sales to customers $ 202 248
Percent Change (as a percent) (18.40%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.    
Sales by segment of business    
Sales to customers $ 154 204
Percent Change (as a percent) (24.80%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International    
Sales by segment of business    
Sales to customers $ 49 44
Percent Change (as a percent) 11.60%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®    
Sales by segment of business    
Sales to customers $ 226 276
Percent Change (as a percent) (18.00%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.    
Sales by segment of business    
Sales to customers $ 148 189
Percent Change (as a percent) (21.60%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International    
Sales by segment of business    
Sales to customers $ 78 87
Percent Change (as a percent) (10.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER    
Sales by segment of business    
Sales to customers $ 374 415
Percent Change (as a percent) (9.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 104 132
Percent Change (as a percent) (21.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | International    
Sales by segment of business    
Sales to customers $ 271 283
Percent Change (as a percent) (4.40%)  
MEDICAL DEVICES    
Sales by segment of business    
Sales to customers $ 6,459 6,767
Percent Change (as a percent) (4.60%)  
MEDICAL DEVICES | U.S.    
Sales by segment of business    
Sales to customers $ 3,109 3,161
Percent Change (as a percent) (1.60%)  
MEDICAL DEVICES | International    
Sales by segment of business    
Sales to customers $ 3,350 3,606
Percent Change (as a percent) (7.10%)  
MEDICAL DEVICES | Diabetes Care    
Sales by segment of business    
Sales to customers $ 0 339
MEDICAL DEVICES | Diabetes Care | U.S.    
Sales by segment of business    
Sales to customers 0 117
MEDICAL DEVICES | Diabetes Care | International    
Sales by segment of business    
Sales to customers 0 222
MEDICAL DEVICES | Interventional Solutions    
Sales by segment of business    
Sales to customers $ 732 640
Percent Change (as a percent) 14.30%  
MEDICAL DEVICES | Interventional Solutions | U.S.    
Sales by segment of business    
Sales to customers $ 343 304
Percent Change (as a percent) 12.60%  
MEDICAL DEVICES | Interventional Solutions | International    
Sales by segment of business    
Sales to customers $ 389 336
Percent Change (as a percent) 15.80%  
MEDICAL DEVICES | Orthopaedics    
Sales by segment of business    
Sales to customers $ 2,204 2,250
Percent Change (as a percent) (2.10%)  
MEDICAL DEVICES | Orthopaedics | U.S.    
Sales by segment of business    
Sales to customers $ 1,318 1,307
Percent Change (as a percent) 0.90%  
MEDICAL DEVICES | Orthopaedics | International    
Sales by segment of business    
Sales to customers $ 885 943
Percent Change (as a percent) (6.20%)  
MEDICAL DEVICES | Orthopaedics | HIPS    
Sales by segment of business    
Sales to customers $ 361 363
Percent Change (as a percent) (0.40%)  
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.    
Sales by segment of business    
Sales to customers $ 213 209
Percent Change (as a percent) 2.10%  
MEDICAL DEVICES | Orthopaedics | HIPS | International    
Sales by segment of business    
Sales to customers $ 148 154
Percent Change (as a percent) (3.80%)  
MEDICAL DEVICES | Orthopaedics | KNEES    
Sales by segment of business    
Sales to customers $ 369 387
Percent Change (as a percent) (4.70%)  
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.    
Sales by segment of business    
Sales to customers $ 223 228
Percent Change (as a percent) (2.20%)  
MEDICAL DEVICES | Orthopaedics | KNEES | International    
Sales by segment of business    
Sales to customers $ 146 159
Percent Change (as a percent) (8.20%)  
MEDICAL DEVICES | Orthopaedics | TRAUMA    
Sales by segment of business    
Sales to customers $ 685 696
Percent Change (as a percent) (1.40%)  
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.    
Sales by segment of business    
Sales to customers $ 417 407
Percent Change (as a percent) 2.50%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | International    
Sales by segment of business    
Sales to customers $ 268 289
Percent Change (as a percent) (7.00%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER    
Sales by segment of business    
Sales to customers $ 788 804
Percent Change (as a percent) (2.20%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 465 463
Percent Change (as a percent) 0.30%  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | International    
Sales by segment of business    
Sales to customers $ 323 341
Percent Change (as a percent) (5.50%)  
MEDICAL DEVICES | Surgery    
Sales by segment of business    
Sales to customers $ 2,395 2,423
Percent Change (as a percent) (1.20%)  
MEDICAL DEVICES | Surgery | U.S.    
Sales by segment of business    
Sales to customers $ 1,001 993
Percent Change (as a percent) 0.80%  
MEDICAL DEVICES | Surgery | International    
Sales by segment of business    
Sales to customers $ 1,394 1,430
Percent Change (as a percent) (2.60%)  
MEDICAL DEVICES | Surgery | ADVANCED    
Sales by segment of business    
Sales to customers $ 980 966
Percent Change (as a percent) 1.50%  
MEDICAL DEVICES | Surgery | ADVANCED | U.S.    
Sales by segment of business    
Sales to customers $ 404 393
Percent Change (as a percent) 2.90%  
MEDICAL DEVICES | Surgery | ADVANCED | International    
Sales by segment of business    
Sales to customers $ 576 573
Percent Change (as a percent) 0.50%  
MEDICAL DEVICES | Surgery | GENERAL    
Sales by segment of business    
Sales to customers $ 1,089 1,127
Percent Change (as a percent) (3.40%)  
MEDICAL DEVICES | Surgery | GENERAL | U.S.    
Sales by segment of business    
Sales to customers $ 425 423
Percent Change (as a percent) 0.30%  
MEDICAL DEVICES | Surgery | GENERAL | International    
Sales by segment of business    
Sales to customers $ 665 704
Percent Change (as a percent) (5.60%)  
MEDICAL DEVICES | Surgery | SPECIALTY    
Sales by segment of business    
Sales to customers $ 325 330
Percent Change (as a percent) (1.40%)  
MEDICAL DEVICES | Surgery | SPECIALTY | U.S.    
Sales by segment of business    
Sales to customers $ 172 177
Percent Change (as a percent) (2.50%)  
MEDICAL DEVICES | Surgery | SPECIALTY | International    
Sales by segment of business    
Sales to customers $ 153 153
Percent Change (as a percent) (0.20%)  
MEDICAL DEVICES | Vision    
Sales by segment of business    
Sales to customers $ 1,129 1,115
Percent Change (as a percent) 1.20%  
MEDICAL DEVICES | Vision | U.S.    
Sales by segment of business    
Sales to customers $ 446 440
Percent Change (as a percent) 1.50%  
MEDICAL DEVICES | Vision | International    
Sales by segment of business    
Sales to customers $ 682 675
Percent Change (as a percent) 1.10%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER    
Sales by segment of business    
Sales to customers $ 824 807
Percent Change (as a percent) 2.10%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.    
Sales by segment of business    
Sales to customers $ 321 309
Percent Change (as a percent) 4.10%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International    
Sales by segment of business    
Sales to customers $ 502 498
Percent Change (as a percent) 1.00%  
MEDICAL DEVICES | Vision | SURGICAL    
Sales by segment of business    
Sales to customers $ 305 308
Percent Change (as a percent) (1.10%)  
MEDICAL DEVICES | Vision | SURGICAL | U.S.    
Sales by segment of business    
Sales to customers $ 125 131
Percent Change (as a percent) (4.50%)  
MEDICAL DEVICES | Vision | SURGICAL | International    
Sales by segment of business    
Sales to customers $ 180 $ 177
Percent Change (as a percent) 1.30%